Julia Karow tracks trends in next-generation sequencing for research and clinical applications for GenomeWeb. Follow her on Twitter at @Julia_Karow.
The revisions, which are subject to approval by the ACMG board of directors, will likely involve the addition of five genes and the removal of one gene from the list.
NHGRI researchers showed that they were able to extract more useful pharmacogenetic information from exome data than from current chip data.
The findings, published last week, have prompted Belgian medical genetics centers to routinely report maternal incidental findings from NIPT.
Last year, Radboud University Medical Centre's genetics lab conducted about 6,000 diagnostic exome tests and ran 2,000 nex-gen sequencing-based BRCA1/2 hereditary cancer assays.
The panel will be offered out of JAX Genomic Medicine's CLIA-certified and CAP-accredited lab and will support Jackson's Maine Cancer Genomics Initiative.
Last week, the G-BA, a committee that decides about reimbursable medical services in Germany, said it will start a methods evaluation of noninvasive prenatal testing.
While undergoing parallel review for its FoundationOne test by the FDA and CMS, the firm will continue to work with its local MACs on reimbursement.
The project has recruited nearly half of the 1,000 families it plans to analyze and has completed the exome analysis for about 160.
Last month, the foundation, in partnership with the Washington State Department of Health, released seven educational videos about prenatal testing.
The test, EXaCT-1, may not only help doctors find treatments for patients who have run out of options but may also provide biomarkers of immunotherapy response.
In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.
The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.
The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.
Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."